MDS

Umbilical cord blood transplantation (CBT), combined with ultra-low-dose methotrexate (uldMTX) as a graft-versus-host disease (GVHD) prophylaxis, provides superior survival for patients with high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), according …

Published: February 3, 2026 Written by: Saul Wisnia Bill Kelley’s unbreakable bond with the clinical team that guided him through myelodysplastic syndrome (MDS), a group of rare blood disorders impacting the bone marrow, and a stem cell transplant was never more evident than during a …

Sergio A. Giralto, MD, professor of medicine at Weill Cornell Medical College, attending physician in the Division of Adult Bone Marrow Transplantation at Memorial Sloan Kettering Cancer Center, vice chief …